Moleculin Biotech, Inc. Operating Leases, Rent Expense
Moleculin Biotech, Inc. (MBRX) reported Operating Leases, Rent Expense of $54.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-02-21
- Moleculin Biotech, Inc. operating leases, rent expense for fiscal 2018 was $54.00K, a 86.21% increase from fiscal 2017.
- Moleculin Biotech, Inc. operating leases, rent expense for fiscal 2017 was $29.00K.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2018-12-31 | $54.00K 10-K · filed 2019-02-21 |
| 2017-12-31 | $29.00K 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |